Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis
Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis
批准号:
10666688
负责人:
Christine A Petersen
金额:
$61.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2027-06-30
关键词:
Animal ModelAntigensArthropodsB-LymphocytesBiological ModelsBiopsyBiteCD8-Positive T-LymphocytesCanis familiarisCellsCessation of lifeClinicalComplexDataDermalDermisDiseaseEnvironmentEpidemiologyErythrocytesEventExposure toFemaleHourHumanImmuneImmune responseImmunityImmunotherapyInfectionInfection ControlInflammationInflammatoryIntegration Host FactorsInterventionIntervention StudiesLaboratoriesLeadLeishmaniaLeishmania donovaniLeishmania infantumLeishmaniasisLigandsLutzomyia genusMacrophageMediatingNorth AmericaOrganOutcomeParasitemiaParasitesPhlebotominaePhlebotomusProductivityPropertyPublic HealthRuptureSalivaSalivarySalivary ProteinsSand FliesSiteSkinSouth AmericaTimeTraumaVisceral LeishmaniasisWorkZoonosescohortexhaustexperimental studyfeedingheme oxygenase-1immunoregulationinnovationpreventprogrammed cell death ligand 1programmed cell death protein 1responsetranscriptometransmission processvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Visceral leishmaniasis (VL), caused by Leishmania donovani complex spp. causes between 20,000-
40,000 deaths a year. L. infantum is the cause of VL in the Mediterranean basin and imported to both South
and North America. L. infantum is zoonotic with canid reservoirs. Leishmania spp. are transmitted primarily
between mammalian hosts by female Lutzomyia or Phlebotomus sand flies. It has been established that both
sand fly and host factors modulate local dermal immunity when and where parasites first encounter skin,
guiding immunity locally and systemically and impacting infection outcomes. Relatively little is known about the
skin immune environment during progressive VL, how dermal immune changes alter host infectiousness or
responses to immunomodulatory sand fly salivary components. Skin parasite burden in dogs with L. infantum
infection correlates with transmission efficiency, more so than parasitemia, though dogs with late-stage
disease were less infectious than those with mild-moderate disease. We have shown that asymptomatic VL
clinical status was associated in dogs, as in humans, with productive Th1 type responses, while symptomatic
infection correlated with presence of exhausted CD4+ and CD8+ T cells, significant expression of Programmed
Death 1 (PD-1) and its ligand, PD-L1 on both B cells and macrophages and loss of macrophage parasite
clearance. These findings collectively lead us to hypothesize that immune cell responses in subclinical or
clinically infected hosts’ skin, whether from dogs or humans, dictate host infectiousness. We will address this
hypothesis through three specific aims in this proposed work, 1) Identify unique dermal immune environments
in subclinical vs. clinical hosts that alter infectiousness to naïve sand flies, 2) Evaluate how the functions of
sand fly salivary proteins are impacted by skin changes during progressive VL leading to new understanding of
vector saliva-host interactions and how they contribute to infectiousness to sand flies and 3) Evaluate how
alteration of the dermal immune environment through dermal immunotherapy alters bite-site inflammation and
transmission. The work proposed here is therefore significant, as it provides infection control relevant
evidence regarding the dermal microenvironment and how it alters infectivity during progressive L infantum
infection. The studies proposed here are significantly innovative as they quantitatively on a spatial level
assess how parasite burden and different dermal inflammatory states alter infectiousness to sand flies. Using
purified salivary antigens, skin biopsy, histopathologic and transcriptome analysis and a key unique natural
infection cohort, we will determine how progressive VL alters the landscape in which vector salivary proteins
operate with consequences for understanding both host infectiousness and the epidemiology of VL. When
completed, findings from these proposed studies will both underscore how progressive dermal inflammation
impacts reservoir host infectiousness and provide critical data to further assess appropriate interventions to
prevent canine-sand fly-human transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis
-
批准号:10527019
-
项目类别:
-
资助金额:$64.96万
-
财政年份:2022
-
负责人:Christine A Petersen
-
依托单位:
Role of pathogen-derived capping carbohydrates in altering immunity
-
批准号:8081281
-
项目类别:
-
资助金额:$10.01万
-
财政年份:2010
-
负责人:Christine A Petersen
-
依托单位:
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC
-
批准号:7960070
-
项目类别:
-
资助金额:$9.54万
-
财政年份:2009
-
负责人:Christine A Petersen
-
依托单位:
Role of pathogen-derived capping carbohydrates in altering immunity
-
批准号:7638500
-
项目类别:
-
资助金额:$21.37万
-
财政年份:2008
-
负责人:Christine A Petersen
-
依托单位:
Role of pathogen-derived capping carbohydrates in altering immunity
-
批准号:7468584
-
项目类别:
-
资助金额:$17.73万
-
财政年份:2008
-
负责人:Christine A Petersen
-
依托单位:
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC
-
批准号:7720072
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2008
-
负责人:Christine A Petersen
-
依托单位:
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC
-
批准号:7610076
-
项目类别:
-
资助金额:$14.18万
-
财政年份:2007
-
负责人:Christine A Petersen
-
依托单位:
Trypanosoma cruzi-elicited cardiac hypertrophy
-
批准号:6612793
-
项目类别:
-
资助金额:$9.49万
-
财政年份:2002
-
负责人:Christine A Petersen
-
依托单位:
Trypanosoma cruzi-elicited cardiac hypertrophy
-
批准号:6735622
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2002
-
负责人:Christine A Petersen
-
依托单位:
Trypanosoma cruzi-elicited cardiac hypertrophy
-
批准号:7038003
-
项目类别:
-
资助金额:$7.97万
-
财政年份:2002
-
负责人:Christine A Petersen
-
依托单位:
Trypanosoma cruzi-elicited cardiac hypertrophy
-
批准号:6506457
-
项目类别:
-
资助金额:$9.28万
-
财政年份:2002
-
负责人:Christine A Petersen
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: